First Create The Media retweeted
Can our pets pick up on our stress? Could your dog save your life? In the latest episode of our myth-busting podcast, Hormones: The Inside Story, our endocrine experts let the cat out of the bag: ow.ly/lp6X50PIcWy #InsideHormones @MedDetectDogs
First Create The Media retweeted
Think that corporate comms is just being a ‘PR shill’? It’s time to think again. Join @Kat_Arney, @FirstCreateMe, and @Dara_Mo, pointSeven, as they lift the lid on what it’s really like to work with companies in the science and health space. absw.org.uk/events/welcome-t…
First Create The Media retweeted
Perfect timing in receiving my SciCom goal that I set myself back in April with @FirstCreateMe at Communicating Your Schience Workshop with @GenSocUK! I have now attended 2 events, and even contributed to a talk and panel discussion with @ERWproject ...and more events to come!🦅
First Create The Media retweeted
“The training I received in clinical bioinformatics was invaluable, providing a springboard for my ongoing research.”
Listen to @RWithaview speaking about his DMT-funded PhD into #epigenetic predictors of #musculoskeletal #ageing.
Read more here: tinyurl.com/2p8z4rpz
First Create The Media retweeted
Our unique Bi-Cygni® approach identifies novel pairs of antigens on cancer cells so we can create bi-specific ADCs that should be safer and more effective.
Read about our latest findings in ADC Review: adcreview.com/news/bvx001-is…
#ADC #antibodydiscovery #drugdevelopment #biotech
First Create The Media retweeted
IICYMI We released our 2022 Annual Report, highlighting progress in identifying a development lead for our BVX001 programme, broadening and strengthening our pipeline, and expanding our team and labs.
bivictrix.com/wp-content/upl…
#drugdevelopment #drugdiscovery #biotech
First Create The Media retweeted
2022 was a busy year for BiVictriX, as you can see from our latest Annual Report. We identified a lead for our BVX001 programme, broadened our pipeline, and expanded our scientific capabilities and premises. Read more: bivictrix.com/wp-content/upl…
#drugdevelopment #pipeline #biotech
First Create The Media retweeted
Coming to @EBDgroup #bioeuropespring next week? Look out for our VP Product Development Oliver Schon to learn more about our unique Bi-Cygni® bispecific antibody platform.
Connect with Oliver on LinkedIn or the conference partnering app for a chat: linkedin.com/in/oliverschon/
First Create The Media retweeted
First Create The Media retweeted
Come and work with us! We're looking for a part-time VP Business Development to join our growing team and deliver on our commercial ambitions.
Find out more and apply on our website: bivictrix.com/working-with-u…
First Create The Media retweeted
Just getting started for @OBN_UK's #Lunchtime #powerhour with the fabulous @Kat_Arney @FirstCreateMe "The Science of Storytelling" #LifeSciences #biotech #startups great to be #Online for @bulbinteriors bit.ly/BulbLabs #scene #storytime
First Create The Media retweeted
Delighted to collaborate again with @Kat_Arney & @GeneticsUnzip for #rarediseaseday2023. Thanks Natalie, Zosia, Joe & Yanick. @jmarshlab @crow_lab
@wendy_bickmore @The_MRC
@The_MRC @UKRI_tweets @GeneticAll_UK @SWAN_UK @DO_Scotland @scotgovhealth @scotgovhealth @CSO_Scotland
NEW EPISODE!
We're looking at rare genetic diseases for #RareDiseaseDay, sponsored by @mrc_hgu @EdinUni_IGC
@jmarshlab describes how advances in computing help geneticists figure out what thousands of rare genetic variants do🧬
Listen to the full story: geneticsunzipped.com/blog/20…
First Create The Media retweeted
Think we're just another regular bi-specific ADC company? Think again. Our Bi-Cygni® approach targets two different antigens on the same cell.
Learn more about our science: bivictrix.com/science/
#ADC #drugdevelopment #biotech #aml #oncology
First Create The Media retweeted
Great to see the promising results of our latest in vivo study written up by ADC Review, comparing our lead bi-specific ADC programme BVX001 against the current ADC therapy. Read more:
adcreview.com/news/bvx001-is…
#ADC #immunotherapy #DrugDevelopment #biotech
First Create The Media retweeted
“These findings move us another step closer to the clinic and provide further evidence that our first-in-class platform offers the potential to deliver the next generation of highly selective, anti-cancer therapies.” More: otp.tools.investis.com/clien… #ADC #oncology #drugdevelopment
First Create The Media retweeted
Watch now: Our CEO Tiffany Thorn discusses exciting new preclinical data on our lead bi-specific ADC programme BVX001 for leukaemia with @proactive_UK
youtu.be/hjO4HaScu2M #ADC #oncology #drugdevelopment #pipeline #investors
First Create The Media retweeted
NEWS: We’re delighted to share positive #data from a preclinical study of our lead programme, BVX001 - a big step towards validating our Bi-Cygni® bispecific ADC platform. Find out more: otp.tools.investis.com/clien… #ADC #oncology #drugdevelopment #investors
First Create The Media retweeted
NEW EPISODE!
What can genetics tell us about our famous ancestors?
When did they live? Where did they live? And did they even know each other?
Here is a geneticist’s version of the tale of Adam and Eve: geneticsunzipped.com/blog/20…
First Create The Media retweeted
Who's coming to #BIOEUROPESPRING? We'll see you there! Connect with our VP product Development Oliver Schon on LinkedIn if you'd like to meet and chat about our game-changing bi-specific ADC platform, Bi-Cygni® linkedin.com/in/oliverschon/ @InformaConnect
First Create The Media retweeted
Application for our amazing Communicating Your Science Workshop are now open. Join @genotripe, @helen_keen, @AlisonWoollard, @Kat_Arney, @FirstCreateMe and more for 3 days where you will explore and develop your communication skills.
genetics.org.uk/grants/comm-…
#scicomm























